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OBJECTIVES The goal of this study was to test and quantify the extent and duration over time of a possible
pressor effect due to ambulatory monitoring.
BACKGROUND The use of ambulatory blood pressure monitoring has provided a method of blood pressure
(BP) assessment that compensates for some of the limitations of office values. While a
“white-coat” pressor effect on conventional measurements has been defined and frequently
used for the improved evaluation of hypertensive patients, there has not been clear indication
that the ambulatory technique could also influence BP.
METHODS We studied 538 mild-to-moderate hypertensive patients (233 men), 54.2  14.2 (mean 
SD) years of age. Blood pressure and heart rate were measured at 20-min intervals during the
day and at 30-min intervals at night for 48 consecutive hours, and physical activity was
simultaneously evaluated at 1-min intervals with a wrist actigraph. One-third of the patients
were evaluated twice or more times.
RESULTS In both treated and untreated hypertensive patients evaluated for the first time, results
indicate a statistically significant (p  0.001) reduction during the second day of monitoring
as compared with the first in the diurnal mean of systolic and diastolic BP, but not in heart
rate or physical activity. This pressor effect remains statistically significant for the first 6 h to
8 h of monitoring independently of gender, days of the week of monitoring or number of
antihypertensive drugs used by the treated patients. The nocturnal mean of BP was, however,
similar between both days of sampling. This “ambulatory monitoring effect” was not observed
when the patients were evaluated after the same sampling scheme for the second or successive
times three months apart.
CONCLUSIONS Ambulatory monitoring for 48 consecutive hours reveals a statistically significant pressor
response that could reflect a novelty effect in the use of the monitoring device for the first
time. This effect has marked implications in both research and clinical daily practice for a
proper diagnosis of hypertension and evaluation of treatment efficacy by the use of ambulatory
monitoring. (J Am Coll Cardiol 2002;40:710–7) © 2002 by the American College of
Cardiology Foundation
Blood pressure (BP) determined casually in the physician’s
office has been commonly used to diagnose hypertension
and to evaluate treatment efficacy (1,2). In chronic hyper-
tensive patients, however, the correlation between the BP
level and target organ damage, cardiovascular risk, and
long-term prognosis is closer for ambulatory blood pressure
monitoring (ABPM) than for clinical measurements (3).
Another advantage of ABPM is that it allows a better
characterization of the patient’s BP during his everyday
activities. Ambulatory BP monitoring seems particularly
useful for defining the efficacy of antihypertensive medica-
tion in clinical trials (4). There are, however, some problems
associated with ABPM. Apart from its relatively high cost,
tolerability of the technique has been discussed as a possible
limitation, mostly because ABPM could induce modest
sleep disturbances (5). Moreover, there seems to be low
individual reproducibility of the circadian profile in BP by
repeated ABPM performed on the same patients (6),
although results again show clear advantages of ABPM over
office values in terms of reproducibility (7).
So far, a large majority of studies have been performed
with ABPM for 24 h. Definitions of “normal” ABPM (8),
criteria for diagnosis of hypertension (1,2,9) and assessment
of antihypertensive therapy (4) have, thus, been established
from data gathered over a single 24-h span. While a
“white-coat” pressor effect associated with conventional or
even self-measurements has been defined and frequently
used ever since for the improved evaluation of hypertensive
patients (10), there has not been a clear indication that the
ABPM technique could also influence BP in patients who
use a somehow sophisticated, expensive and unusual device
for the first time. If that should be the case, 24 h could be
insufficient for a proper evaluation of the circadian variation
in BP (6,11–14). With the objective to test and quantify the
extent and duration over time of a possible ABPM pressor
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effect, we have assessed the day-to-day variations in BP and
physical activity in patients with mild-to-moderate essential
hypertension sampled for 48 consecutive hours.
METHODS
Subjects. We studied 538 patients (233 men and 305
women), 54.2  14.2 years of age (range, 22 to 88 years),
with diagnoses of mild-to-moderate essential hypertension,
according to the recent World Health Organization–
International Society of Hypertension classification (2).
Among those, 190 patients (35.3%) were not receiving any
treatment at the time of their first evaluation by ABPM. All
patients received medical care at the Hypertension and
Vascular Risk Unit, Hospital Clı´nico Universitario, San-
tiago de Compostela, Spain. Shift workers and patients with
either “white-coat” hypertension, according to the defini-
tions provided by the Joint National Committee VI (1) and
the World Health Organization–International Society of
Hypertension (2), severe arterial hypertension, secondary
arterial hypertension, cardiovascular disorders other than
essential hypertension, or obstructive sleep apnea were
excluded from analysis.
BP assessment. The systolic blood pressure (SBP) and
diastolic blood pressure (DBP), and heart rate (HR) of each
patient were automatically measured every 20 min during
the day (7:00 AM to 11:00 PM) and every 30 min during the
night for 48 consecutive hours with a SpaceLabs 90207
(SpaceLabs Inc., Redmond, Washington) device. Due to
this sampling scheme, ABPM always starts on Monday,
Wednesday, or Friday. In order to keep a possible “white-
coat” effect to a minimum, only the first BP measurement
was performed at the medical setting to validate the proper
functioning of the ABPM device. Patients are systematically
reevaluated by ABPM in our unit three months after either
starting therapy, changing or increasing the number of
drugs, or modifying the time or dose of medication. Ac-
cordingly, among the subjects participating in the study, 161
were studied two or more times, always three months apart.
Subjects were assessed while adhering to their usual diurnal
activity (8:00 AM to 11:00 PM for most)-nocturnal sleep
routine. They were instructed to go about their usual
activities with minimal restrictions but to follow a similar
schedule during the two days of ABPM. No person was
hospitalized during monitoring. Blood pressure series (a
total of 40) were eliminated from analysis when the subjects
showed an irregular rest-activity schedule during the two
days of sampling, an odd sampling with spans of 3 h
without BP measurement, or a night resting span 6 h or
12 h.
The clinical evaluation of this oscillometric monitor
according to the standards published by the Association for
Advancement of Medical Instrumentation and the British
Hypertension Society has been previously established (15).
The BP cuff was worn on the nondominant arm with cuff
size determined by upper arm circumference at each study
visit. Ambulatory blood pressure monitoring always began
between 10:00 AM and noon. During monitoring each
subject maintained a diary listing the times they went to bed
at night, woke in the morning, and ate meals; exercise and
unusual physical activity; and events and mood/emotional
states that might affect BP. The results presented herein are
based on a total of 734 protocol-correct 48-h BP time series
collected from the 538 patients.
Actigraphy. The patients wore a MiniMotionLogger acti-
graph (Ambulatory Monitoring Inc., Ardsley, New York)
on the dominant wrist to monitor physical activity every
minute at the time of ABPM. This compact (about half the
size of a wrist watch) device functions as an accelerometer.
The clock time of the actigraph and the ABPM device were
always synchronized through their respective interfaces with
the same computer. The mean activity for the 5 min before
each BP reading was then calculated for analysis, according
to previous studies in this area (16).
Statistical methods. Each individual’s clock hour BP, HR,
and activity values were first re-referenced from clock time
to hours before and after awakening from nocturnal sleep,
according to the information obtained from actigraphy.
This transformation avoided the introduction of bias due to
differences among subjects in their sleep/activity routine
(12). Blood pressure and HR time series were then edited
according to conventional criteria to remove measurement
errors and outliers (17). Because activity is not normally
distributed, analyses for this variable were done before and
after logarithmic transformation. The conclusions from
both analyses were practically identical, and, therefore,
activity is expressed in original units because this can be
more meaningful for those using the same or comparable
devices.
The circadian rhythm of BP, HR, and activity for the first
and second days of ABPM was objectively assessed by
population multiple-component analysis (18), a method
applicable to nonsinusoidal-shaped hybrid time series data
(time series of data collected from a group of subjects)
consisting of values distributed at equal or unequal intervals.
The circadian rhythm parameters thus obtained were com-
pared between consecutive days of ABPM by a nonpara-
metric paired test developed to assess differences in param-
eters derived from population multiple-components analysis
(18). Hourly means of each variable were compared between
days by t test corrected for multiple testing using Holm’s
procedure (19,20). Average differences for the first 4 h of
measurement between the first and the second days of
Abbreviations and Acronyms
ABPM  ambulatory blood pressure monitoring
ANOVA  analysis of variance
BP  blood pressure
DBP  diastolic blood pressure
HR  heart rate
SBP  systolic blood pressure
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ABPM were compared by two-way repeated measures
analysis of variance (ANOVA) among groups of treated and
untreated patients evaluated for the first or successive times,
divided as a function of gender, day of the week of
monitoring, and number of antihypertensive drugs used for
treatment.
RESULTS
The circadian rhythm of SBP, DBP, HR, and activity in
untreated hypertensive patients measured for the first time
by ABPM, established separately for data sampled on the
first and second days of a 48-h consecutive ABPM span, is
depicted in Figure 1. Results indicate a statistically signifi-
cant BP reduction during the second day of ABPM as
compared with the first (p  0.001 for the comparison of
the 24-h mean). This reduction is statistically significant,
after correction for multiple testing, in both SBP and DBP
for the 4 h to 5 h immediately after the start of ABPM (2
h to 3 h after awakening in most subjects; shadowed area in
Fig. 1). For the first 4 h of measurement (Table 1), the
second day of ABPM is characterized by an average reduc-
tion of 5.7 and 4.2 mm Hg in SBP and DBP, respectively,
as compared with the first day of monitoring (p  0.001 for
both variables). Individually, this “ABPM pressor effect”
was documented in 74% of the untreated patients. Because
the effect lasts just a few hours, the nocturnal means of BP
were similar between both days of sampling (differences of
0.15 and 0.12 mm Hg for SBP and DBP; p  0.564).
Thus, the reduction in 24-h mean during the second day of
measurement is, although significant, rather small (about
1.5 mm Hg). As a consequence of the decrease in BP during
diurnal activity but not during nocturnal resting hours, 32%
of the patients characterized as dippers during the first day
of ABPM became nondippers in the second day of mea-
surement. Despite the highly significant differences in BP
between consecutive days of ABPM, there were no differ-
ences in daily (24-h), diurnal, nocturnal or even any of the
24 hourly means in HR or physical activity between the first
and the second days of monitoring (bottom graphs of Fig. 1).
For hypertensive patients receiving antihypertensive
medication at the time of their first evaluation by ABPM,
results indicate a statistically significant BP reduction during
the second day of monitoring for about 6 to 7 consecutive
hours (shadowed area in graphs on the top of Fig. 2),
although the effect seems to be significant for about the first
9 h of measurement. The average BP difference between
days of sampling for the first 4 h of ABPM was 6.8 mm Hg
for SBP and 4.9 mm Hg for DBP (Table 1). This “ABPM
effect” is documented in 72% of the treated patients in this
study. There was no significant difference in nocturnal mean
nor in any of the hourly means during nocturnal rest
between the two days of ABPM (Fig. 2). Results indicate,
however, a significant reduction of 4.5 mm Hg in the
diurnal mean of SBP (2.4 mm Hg for DBP). About 36% of
the dipper patients became nondippers during the second
day of measurement. Results further indicate the absence of
any significant difference between consecutive days of mon-
itoring in HR or physical activity (bottom graphs of Fig. 2).
The comparison between consecutive days of ABPM in
patients studied for the second or successive time indicates
the lack of any statistically significant difference in daily,
diurnal, nocturnal or hourly means of BP, HR and activity
(p  0.232 in all cases; Fig. 3). The larger, but not
significant, difference (after correction for multiple testing)
between days of sampling in BP was obtained at about 3 h
after awakening, that is, close to the time when ABPM
started for most patients. This difference could represent the
expected “white-coat” effect at the office.
Because the “ABPM effect” seems to persist for at least
the first 4 h of sampling, we evaluated possible confounding
factors in this pressor effect by comparing the average
differences for the first 4 h of measurement between the first
and second days of ABPM among groups of patients
evaluated for the first or successive times, divided as a
function of gender, day of the week of monitoring and
number of antihypertensive drugs used for treatment. Re-
sults indicate a significant “ABPM effect” for every sub-
group of patients who were evaluated for the first time (first
two columns in Table 1). Although the effect seems to be
consistently higher among treated patients, there is no
statistically significant difference in the extent of BP change
between any subgroup of treated and untreated patients (last
column in Table 1). Differences are, however, significant in
SBP and DBP for almost every subgroup studied when one
compares treated and untreated patients studied for the first
time with those evaluated for the second or successive times
(fourth column in Table 1). The nonsignificant difference in
DBP among the three groups being compared for ABPM
starting on Wednesday becomes significant (p  0.045)
when the third group (second ABPM) is compared with the
composite of the first two (first ABPM, independently of
treatment). The comparison by two-way ANOVA of the
“ABPM effect” between days of the week of sampling
indicates the lack of differences for each of the three groups
studied (p 0.354 for both SBP and DBP). Similarly, there
is no statistically significant difference in the extent of the
“ABPM effect” as a function of the number of antihyper-
tensive drugs used by the treated patients (p  0.747).
DISCUSSION
Hypertensive patients seem to exhibit a greater day-to-day
variability in BP than normotensive subjects (11). Although
most studies assessing the circadian BP profile have used
24-h ABPM, as a compromise with practicality, monitoring
over at least 48 h has been shown to present advantages in
the analysis of BP variability (11–13), diagnosis of disease
(14) and evaluation of a patient’s response to treatment (13).
The individualized estimation of rhythm characteristics
become more reliable; new end points are obtained, such as
the circadian period, that cannot usually be estimated from
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Figure 1. Differences in the circadian pattern of systolic and diastolic blood pressure, heart rate, and activity between the first and the second day of a 48-h
ambulatory blood pressure monitoring (ABPM) in untreated patients with mild-to-moderate hypertension measured for the first time. Each graph shows
the hourly means and standard errors of data collected during the first (continuous line) and second (dashed line) day of monitoring. The
nonsinusoidal-shaped curve represented for each day corresponds to the best-fitted waveform model determined by population-multiple-component
analysis (with corresponding characteristics given in the table below each graph). The arrows descending from the upper horizontal axis point to the
circadian orthophase (rhythm’s crest time) for each day of monitoring.
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24-h records (21). Thus, previous results suggested that
ABPM done only for 24 h may be too short to characterize
accurately the features of the day-night variation in BP,
including the precise period of that variation (21).
Results from this study indicate that BP is significantly
affected by the novelty of wearing an ABPM device for the
first time. This “ABPM effect” increases BP on the average
by a significant 7 mm Hg and 4 mm Hg for SBP and DBP,
respectively, for the first 4 h of measurement. This pressor
effect, individually documented in about 73% of all hyper-
tensive patients evaluated by 48-h ABPM in this study,
persists as statistically significant for up to 9 h after patients
start wearing the device. Due to the lack of differences in
nocturnal BP values, the effect on the 24-h mean is lower
than the differences between consecutive days of monitoring
shown for the diurnal mean of BP (above 4 mm Hg for
SBP). This increase in BP is not related to any change in
HR or physical activity (Figs. 1 and 2). Further evidence
that the ABPM effect reflects a pressor response to the
novelty of the device comes from the results represented in
Figure 3. Differences between consecutive days of ABPM
are no longer significant when hypertensive patients are
evaluated for the second or successive times. Moreover, the
pressor response to ABPM seems to be independent of
possible confounding factors such as the use of antihyper-
tensive medication, gender, day of the week of monitoring
and number of antihypertensive drugs used for treatment
(Table 1).
The significant ABPM effect shown in the first but not in
successive BP profiles raises the question of its potential
influence on the results from trials designed to evaluate
treatment efficacy based on ABPM for only 24 h. Along
these lines, the need for a placebo group in clinical trials
with ABPM is still under debate. In a study by Mancia et al.
(22), administration of placebo for six to eight weeks was
accompanied by no change in 24-h, daytime or night-time
BP averages. However, SBP during the initial 4 h of the
monitoring was slightly but significantly lower after placebo
treatment (by 3.1 mm Hg, p  0.05) compared with
baseline values. Although the authors did not perform
ABPM beyond 24 h, the placebo effect that they though
was a consequence of a “white-coat” effect could, indeed, be
just an indication of the “ABPM effect” documented in
Figures 1 to 3. Because the “ABPM effect” persists for hours
after the patient leaves the hospital setting, but it is
significantly attenuated with repeated evaluations by
ABPM, it cannot be considered as a manifestation of the
“white-coat” effect (10).
Another relevant issue is the reproducibility of the dif-
ferences between diurnal and nocturnal BP in hypertensive
patients. Thus, results associating the lack of nocturnal
decline in BP (nondipping) with an increase in end-organ
Table 1. Blood Pressure Differences for the First 4 h of Measurement Between the First and Second Days of a 48-h ABPM in
Patients With Mild-to-Moderate Hypertension
Group/Variable
1st ABPM
2nd and Successive
ABPM
p Value for Comparison
Untreated Treated All Groups First 2 Groups
All subjects, n of series 190 348 196
SBP 5.7  0.7 6.8  0.7 1.6  0.6 0.001 0.277
DBP 4.2  0.5 4.9  0.4 2.0  0.5 0.001 0.318
Men 89 144 86
SBP 6.3  1.0 5.9  1.0 2.5  0.9 0.027 0.820
DBP 4.3  0.7 4.3  0.6 2.4  0.7 0.036 0.987
Women 101 204 110
SBP 5.2  0.9 7.4  0.9 0.81  0.9 0.001 0.115
DBP 4.2  0.6 5.4  0.6 1.68  0.7 0.001 0.213
ABPM starting on Monday 77 119 72
SBP 6.0  1.1 8.9  1.1 1.6  1.1 0.001 0.080
DBP 4.4  0.7 6.0  0.6 2.0  0.8 0.001 0.093
ABPM starting on Wednesday 61 117 65
SBP 4.4  1.1 6.2  1.1 2.4  0.9 0.031 0.281
DBP 3.9  0.8 4.1  0.8 2.1  0.8 0.132 0.867
ABPM starting on Friday 52 112 59
SBP 6.8  1.2 5.2  1.2 0.7  1.2 0.011 0.424
DBP 4.5  1.0 4.6  0.8 1.9  0.8 0.035 0.913
Patients receiving 1 drug 169 76
SBP 6.6  0.9 2.5  0.9 0.004
DBP 4.8  0.6 1.0  0.7 0.001
Patients receiving 2 drugs 104 48
SBP 5.6  1.2 1.5  1.5 0.044
DBP 4.1  0.8 2.6  1.0 0.155
Patients receiving 3 or more drugs 75 40
SBP 8.9  1.7 0.5  1.6 0.001
DBP 6.2  1.0 0.6  1.2 0.001
All values given in mean  SE.
ABPM  ambulatory blood pressure monitoring; DBP  diastolic blood pressure; SBP  systolic blood pressure.
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Figure 2. Differences in the circadian pattern of systolic and diastolic blood pressure, heart rate, and activity between the first and the second day of a 48-h
ambulatory blood pressure monitoring (ABPM) in treated patients with mild-to-moderate hypertension measured for the first time. Each graph shows the
hourly means and standard errors of data collected during the first (continuous line) and second (dashed line) day of monitoring. The nonsinusoidal-
shaped curve represented for each day corresponds to the best-fitted waveform model determined by population-multiple-component analysis (with
corresponding characteristics given in the table below each graph). The arrows descending from the upper horizontal axis point to the circadian orthophase
(rhythm’s crest time) for each day of monitoring.
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Figure 3. Lack of differences in the circadian pattern of systolic and diastolic blood pressure, heart rate, and activity between the first and the second day
of a 48-h ambulatory blood pressure monitoring (ABPM) in patients with mild-to-moderate hypertension measured for the second or successive times.
Each graph shows the hourly means and standard errors of data collected during the first (continuous line) and second (dashed line) session of monitoring,
determined three months apart. The nonsinusoidal-shaped curve represented for each session corresponds to the best-fitted waveform model determined
by population-multiple-component analysis (with corresponding characteristics given in the table below each graph). The arrows descending from the
upper horizontal axis point to the circadian orthophase (rhythm’s crest time) for each session of monitoring.
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damage and cardiovascular events (3) are still controversial,
partly due to the inability to properly reproduce over time
the classification of patients into dippers and nondippers
(6,23). Along these lines, the pressor effect due to ABPM
significantly increases BP during at least half of the diurnal
active hours, without modifying the nocturnal BP (Figs. 1
and 2). As a consequence, there is a significant increase in
the total number of nondippers when this classification is
obtained on the basis of data sampled during the second day
of ABPM as compared with the first. The “ABPM effect”
could, thus, provide an underestimation of the real percent-
age of nondippers among patients with mild-to-moderate
hypertension (6).
In summary, the results in Figures 1 to 3 document an
ABPM effect on BP independent of any change in the
activity pattern or any apparent modification in HR. The
ABPM effect observed during the first few hours of sam-
pling has marked implications in clinical trials for evaluation
of antihypertensive medications because this pressor re-
sponse could lead to some overestimation of the peak effect
of the drug and underestimation of the trough:peak ratio.
The results further indicate that ABPM for just 24 h may be
insufficient for a proper diagnosis of hypertension, evalua-
tion of treatment efficacy and identification of dipping status
in relation to target-organ damage.
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